Blog Posts, Company News & Culture
The Belgrade team helping to make AI drug history
Media Highlights
Science Magazine: Computing Our Way to Antibodies
GEN: Absci Eyes IND for Platform’s First de novo Antibody within Two Years
Press Releases
University of Oxford’s Kennedy Institute of Rheumatology Partners with Absci to Accelerate AI-Driven Immunotherapies
